Trial Details

COMPLETED
Basic Information
Clinical ID c1205
Identifier NCT00656890
Trial Title A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions BIOLOGICAL: sterile saline for injection|BIOLOGICAL: MDX-1100
Participant Information
Sponsor Bristol-Myers Squibb
City Port Orange
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-04-08
Primary Completion Date 2025-09-09
Completion Date 2025-09-09